Fundraising FoxTissue Regeneration Sciences
1 known investors
Find your way into Tissue Regeneration Sciences
Sign up to see every warm intro you have to Tissue Regeneration Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tissue Regeneration Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
An early-stage biotechnology company developing tissue-regenerative therapies based on the biotherapeutic calreticulin, with a first focus on a topical drug for diabetic foot ulcers. Its pipeline targets chronic and acute wound healing, corneal ulcers, soft tissue augmentation, and hair follicle regeneration.
Investors · 1
Frequently asked questions
- What does Tissue Regeneration Sciences do?
- An early-stage biotechnology company developing tissue-regenerative therapies based on the biotherapeutic calreticulin, with a first focus on a topical drug for diabetic foot ulcers. Its pipeline targets chronic and acute wound healing, corneal ulcers, soft tissue augmentation, and hair follicle regeneration.
- Who are Tissue Regeneration Sciences's investors?
- Tissue Regeneration Sciences's investors include NYU Innovation Venture Fund.